Skip to main content
. Author manuscript; available in PMC: 2016 Jul 13.
Published in final edited form as: JAMA. 2008 May 14;299(18):2164–2171. doi: 10.1001/jama.299.18.2164

Table 2.

Fistula Thrombosis

No. (%) of Patients Relative Risk
(95% Confidence Interval)b
Clopidogrel
(n = 435)a
Placebo
(n = 431)a
Thrombosis at 6 wk (all patients) 53 (12.2) 84 (19.5) 0.63 (0.46–0.97)c
By location
  Forearm fistula 31 (12.9) 60 (24.7) 0.53 (0.36–0.77)
  Upper arm fistula 22 (11.3) 24 (12.8) 0.89 (0.52–1.53)
a

Six of the 441 patients randomized to clopidogrel and 5 of the 436 patients randomized to placebo were not included because patency was not evaluated.

b

Relative risks were stratified for fistula location and center.

c

The 95% confidence interval reported is the repeated confidence interval adjusted for interim monitoring. The repeated P value adjusted for interim monitoring is .018.